Taekwondo for axial spondyloarthritis
Part of Bones, joints & muscles clinical trials.
This study tests whether Taekwondo (a martial art) can help people with axial spondyloarthritis, a type of arthritis that affects the spine and pelvis. It looks at pain, stiffness, and quality of life, and may offer a new way to stay active and feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 59 years old.
- You have been diagnosed with axial spondyloarthritis (a type of arthritis that affects your spine and pelvis).
- Your medications for this condition have been stable for the past 3 months, or you haven't taken any meds for it in that time.
- You have not had any orthopedic surgery or bone fracture in the last 12 months.
- You do not have major heart problems, advanced spine fusion, cancer in the last 5 years, or are pregnant.
- You have not been regularly exercising (like 60 minutes or more, 3 times a week) in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a structured, high-intensity exercise program can improve symptoms in people with axial spondyloarthritis. It compares the exercise approach against another group to see if it helps function and well-being.
This trial is for people with ankylosing spondylitis (a type of arthritis that affects the spine) who are otherwise healthy. It may test a treatment to see if it helps control symptoms, whether your disease is active or stable.
This trial studies an advanced “sensor-based” way to assess how your spine and hips move in people with axial spondyloarthritis. It may help researchers better measure function and choose/monitor treatment, especially for those considered for biologic therapy.
This study tests whether wearing a Fitbit activity tracker and using a Google Health app can help people with axial spondyloarthritis (a type of spine arthritis) become more physically active. The goal is to see if this technology-based approach motivates people to exercise more, which may help reduce pain and improve their condition.
This trial tests whether tofacitinib (a pill that reduces inflammation) can help people with early-stage axial spondyloarthritis, a type of arthritis that mainly affects the spine and pelvis. It's for those who have had symptoms for 2 years or less and have active disease with signs of inflammation in MRI or blood tests.
This trial tests an investigational medication called SCT650C for people with active axial spondyloarthritis. It aims to see if it can reduce pain and inflammation better than current treatments.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.